L OREAL CO/ADR (OTCMKTS:LRLCY) Lowered to “Hold” at Zacks Investment Research

Share on StockTwits

Zacks Investment Research lowered shares of L OREAL CO/ADR (OTCMKTS:LRLCY) from a buy rating to a hold rating in a research note published on Saturday, Zacks.com reports.

According to Zacks, “At L’Oréal, they have made cosmetics the focus of all their energy and know-how for nearly a century. They are fully committed to putting their expertise and research resources to work for the well-being of men and women, in all their diversity, around the world. “

Several other brokerages have also weighed in on LRLCY. HSBC started coverage on L OREAL CO/ADR in a report on Friday, June 28th. They issued a hold rating for the company. ValuEngine lowered L OREAL CO/ADR from a buy rating to a hold rating in a report on Thursday, August 1st. One analyst has rated the stock with a sell rating, four have given a hold rating and one has given a buy rating to the stock. The company has a consensus rating of Hold and a consensus target price of $64.00.

Shares of LRLCY opened at $51.20 on Friday. The business has a 50-day moving average price of $56.09. L OREAL CO/ADR has a fifty-two week low of $42.01 and a fifty-two week high of $58.18. The stock has a market cap of $148.41 billion, a price-to-earnings ratio of 30.66, a P/E/G ratio of 5.16 and a beta of 0.55.

About L OREAL CO/ADR

L'Oréal SA, through its subsidiaries, manufactures and sells cosmetic products for women and men worldwide. It operates through four divisions: Consumer Products, L'oréal Luxe, Professional Products, and Active Cosmetics. It offers shampoos, hair care products, shower gels, skin care products, cleansers, hair colors, styling products, deodorants, sun care products, make-up, perfumes, etc.

Recommended Story: How does new data get added to a blockchain?

Get a free copy of the Zacks research report on L OREAL CO/ADR (LRLCY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for L OREAL CO/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for L OREAL CO/ADR and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

SpartanNash  Lifted to “Hold” at ValuEngine
SpartanNash Lifted to “Hold” at ValuEngine
ValuEngine Lowers Sportsman’s Warehouse  to Sell
ValuEngine Lowers Sportsman’s Warehouse to Sell
Sorrento Therapeutics  Raised to “Hold” at Zacks Investment Research
Sorrento Therapeutics Raised to “Hold” at Zacks Investment Research
Sierra Oncology  Upgraded at Zacks Investment Research
Sierra Oncology Upgraded at Zacks Investment Research
Zacks Investment Research Lowers Sierra Oncology  to Hold
Zacks Investment Research Lowers Sierra Oncology to Hold
StoneCo  Earns “Buy” Rating from Bank of America
StoneCo Earns “Buy” Rating from Bank of America


© 2006-2019 Ticker Report